title: Reply to 'Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab'.
authors.affiliation: Dennis Lam & Partners Eye Center, Hong Kong, China.
authors.forename: M
authors.initials: M
authors.lastname: Ho
authors.affiliation: Dennis Lam & Partners Eye Center, Hong Kong, China.
authors.forename: E C
authors.initials: EC
authors.lastname: Lo
authors.affiliation: Dennis Lam & Partners Eye Center, Hong Kong, China.
authors.forename: A L
authors.initials: AL
authors.lastname: Young
authors.affiliation: Dennis Lam & Partners Eye Center, Hong Kong, China.
authors.forename: D T L
authors.initials: DT
authors.lastname: Liu
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010778:Photochemotherapy; D011127:Polyps / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized